CARLOMAGNO, Chiara
CARLOMAGNO, Chiara
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Cancro del colon-retto
2007 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models
2012 Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
2007 T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart
Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study
2006 M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses.
2015 Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone
FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic coloectal cancer (MCRC): results of the phase III tandomized TRIBE trial
2013 Luopakis, F; Cremolini, C; Masi, G; Lonardi, S; Zagonel, V; Trenta, P; Tomasello, G; Ronzoni, M; Ciuffreda, L; Zaniboni, A; Tonini, G; Buonadonna, A; Valsuani, C; Chiara, S; Carlomagno, Chiara; Boni, C; Marcucci, L; Boni, L; Falcone, A.
Ovarian metastasis following gallbladder carcinoma: a case report.
2010 Carlomagno, Chiara; Insabato, Luigi; Bifulco, Giuseppe; DE PLACIDO, Sabino; Lauria, R.
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.
2013 Malapelle, Umberto; Bellevicine, Claudio; DE LUCA, Caterina; Salatiello, M; DE STEFANO, Alfonso; Rocco, D; de Rosa, N; Vitiello, F; Russo, S; Pepe, F; Iaccarino, A; Micheli, P; Illiano, A; Carlomagno, Chiara; Piantedosi, Fv; Troncone, Giancarlo
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
2011 Mcgale, P; Correa, C; Taylor, C; Arriagada, R; Clarke, M; Cutter, D; Davies, C; Ewertz, M; Godwin, J; Gray, R; Pierce, L; Whelan, T; Wang, Y; Peto, R; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience
2013 Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
1995 F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE
Prognostic factors in human colorectal cancer.
1997 A. R., Bianco; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; G., Tortora; F., Ciardiello
Correlation between bevacizumab-related hypertension and response in mCRC patients
2010 DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino
Guillain Barrè syndrome associated with gastric cancer: paraneoplastic syndrome or immunological disorder?
2010 Colantuoni, Maria; Matano, E; Alfieri, Salvatore; DE PLACIDO, Sabino; Carlomagno, Chiara
Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
2008 Popov, I; Carrato, A; Sobrero, A; Vincent, M; Kerr, D; Labianca, R; Bianco, Ar; El Serafi, M; Bedenne, L; Paillot, B; Mini, E; Sanches, E; Welch, J; Colette, L; Praet, M; Wils, J; Carlomagno, Chiara
Cancro del colon-retto
1999 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
Skin lesions: unusual presentation of gastric cancer
2009 Alfieri, S; Carlomagno, Chiara; Colantuoni, M; De Stefano, A; Cannella, L; Cella, Ca; DE PLACIDO, Sabino
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS
2009 M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
| Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models | 1.5 Abstract in rivista | 2012 | Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino | |
| Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial | 1.5 Abstract in rivista | 2007 | T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart | |
| Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study | 1.5 Abstract in rivista | 2006 | M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita | |
| FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses. | 1.5 Abstract in rivista | 2015 | Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone | |
| FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic coloectal cancer (MCRC): results of the phase III tandomized TRIBE trial | 1.5 Abstract in rivista | 2013 | Luopakis, F; Cremolini, C; Masi, G; Lonardi, S; Zagonel, V; Trenta, P; Tomasello, G; Ronzoni, M; Ciuffreda, L; Zaniboni, A; Tonini, G; Buonadonna, A; Valsuani, C; Chiara, S; Carlomagno, Chiara; Boni, C; Marcucci, L; Boni, L; Falcone, A. | |
| Ovarian metastasis following gallbladder carcinoma: a case report. | 1.1 Articolo in rivista | 2010 | Carlomagno, Chiara; Insabato, Luigi; Bifulco, Giuseppe; DE PLACIDO, Sabino; Lauria, R. | |
| EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. | 1.1 Articolo in rivista | 2013 | Malapelle, Umberto; Bellevicine, Claudio; DE LUCA, Caterina; Salatiello, M; DE STEFANO, Alfonso; Rocco, D; de Rosa, N; Vitiello, F; Russo, S; Pepe, F; Iaccarino, A; Micheli, P; Illiano, A; Carlomagno, Chiara; Piantedosi, Fv; Troncone, Giancarlo | |
| Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. | 1.1 Articolo in rivista | 2011 | Mcgale, P; Correa, C; Taylor, C; Arriagada, R; Clarke, M; Cutter, D; Davies, C; Ewertz, M; Godwin, J; Gray, R; Pierce, L; Whelan, T; Wang, Y; Peto, R; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 1.1 Articolo in rivista | 2003 | DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE | |
| FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience | 1.1 Articolo in rivista | 2013 | Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| First-line systemic therapy for metastatic breast cancer and management of pleural effusion. | 1.1 Articolo in rivista | 1995 | F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE | |
| Prognostic factors in human colorectal cancer. | 1.1 Articolo in rivista | 1997 | A. R., Bianco; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; G., Tortora; F., Ciardiello | |
| Correlation between bevacizumab-related hypertension and response in mCRC patients | 1.5 Abstract in rivista | 2010 | DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino | |
| Guillain Barrè syndrome associated with gastric cancer: paraneoplastic syndrome or immunological disorder? | 1.1 Articolo in rivista | 2010 | Colantuoni, Maria; Matano, E; Alfieri, Salvatore; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). | 1.1 Articolo in rivista | 2008 | Popov, I; Carrato, A; Sobrero, A; Vincent, M; Kerr, D; Labianca, R; Bianco, Ar; El Serafi, M; Bedenne, L; Paillot, B; Mini, E; Sanches, E; Welch, J; Colette, L; Praet, M; Wils, J; Carlomagno, Chiara | |
| Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 1999 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
| Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
| Skin lesions: unusual presentation of gastric cancer | 1.5 Abstract in rivista | 2009 | Alfieri, S; Carlomagno, Chiara; Colantuoni, M; De Stefano, A; Cannella, L; Cella, Ca; DE PLACIDO, Sabino | |
| MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS | 1.5 Abstract in rivista | 2009 | M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino |